Cargando…
Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation
A coherent account of the reaction mechanistic details, structural modifications, and inhibition potentials of antineoplastic drug carmofur and its modified analogs to inhibition of SARS-CoV-2 main protease (M(pro)) is reported. The survey is performed by integrating the density functional based tig...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656244/ https://www.ncbi.nlm.nih.gov/pubmed/34904062 http://dx.doi.org/10.1016/j.rechem.2021.100259 |
_version_ | 1784612245364277248 |
---|---|
author | Hemati, Niloofar Hadidi, Saba Shiri, Farshad Farzaei, Mohammad Hosein |
author_facet | Hemati, Niloofar Hadidi, Saba Shiri, Farshad Farzaei, Mohammad Hosein |
author_sort | Hemati, Niloofar |
collection | PubMed |
description | A coherent account of the reaction mechanistic details, structural modifications, and inhibition potentials of antineoplastic drug carmofur and its modified analogs to inhibition of SARS-CoV-2 main protease (M(pro)) is reported. The survey is performed by integrating the density functional based tight binding (DFTB3) with density functional theory (DFT) calculations. The inhibition process commences with nucleophilic attack from the sulfur atom on the carbonyl group, yielding a C-S bond formation, followed by a bond formation of the H-O9 by 2.07 Å, which results in a transition state contains a ring of six atoms. We found that although the direct addition of sulfhydryl group hydrogen to the N3 position is likely to happen, the proper position of the hydrogen to O9 decreases its accessibility. The thermodynamic stability of the complex was calculated to be highly sensitive to the substituent on the N11 position. Compounds with CH(2)NH(2) and CH(2)F at N11 positions of carmofur revealed high thermodynamic stability to complexation with M(pro) but induced no change in substrate-binding pocket comparable to carmofur. Replacing the N11 of carmofur with carbon (C-carmofur) was effective in terms of complexation stability at CH(2)CH(2)CH(2)F and CH(2)CH(2)CH(2)OH substitutions and occupation of S1 subsite by these structures in addition to the S2 subsite. Based on the resulted data, increasing the length of the carbon chain at introduced substitutions in N-carmofur almost decreases the complexation stability while in C-carmofur the trend is reversed. Throughout these information outputs, it was suggested that compounds d, e, i′, and k′ might be novel and more efficacious drug candidates instead of carmofur. We believe that our characterization of mechanistic details and structural modification on M(pro)/carmofur complex will significantly intensify researchers' understanding of this system, and consequently help them to take advantage of results into practice and design various valuable derivatives for inhibition of SARS-CoV-2 main protease. |
format | Online Article Text |
id | pubmed-8656244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86562442021-12-09 Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation Hemati, Niloofar Hadidi, Saba Shiri, Farshad Farzaei, Mohammad Hosein Results Chem Article A coherent account of the reaction mechanistic details, structural modifications, and inhibition potentials of antineoplastic drug carmofur and its modified analogs to inhibition of SARS-CoV-2 main protease (M(pro)) is reported. The survey is performed by integrating the density functional based tight binding (DFTB3) with density functional theory (DFT) calculations. The inhibition process commences with nucleophilic attack from the sulfur atom on the carbonyl group, yielding a C-S bond formation, followed by a bond formation of the H-O9 by 2.07 Å, which results in a transition state contains a ring of six atoms. We found that although the direct addition of sulfhydryl group hydrogen to the N3 position is likely to happen, the proper position of the hydrogen to O9 decreases its accessibility. The thermodynamic stability of the complex was calculated to be highly sensitive to the substituent on the N11 position. Compounds with CH(2)NH(2) and CH(2)F at N11 positions of carmofur revealed high thermodynamic stability to complexation with M(pro) but induced no change in substrate-binding pocket comparable to carmofur. Replacing the N11 of carmofur with carbon (C-carmofur) was effective in terms of complexation stability at CH(2)CH(2)CH(2)F and CH(2)CH(2)CH(2)OH substitutions and occupation of S1 subsite by these structures in addition to the S2 subsite. Based on the resulted data, increasing the length of the carbon chain at introduced substitutions in N-carmofur almost decreases the complexation stability while in C-carmofur the trend is reversed. Throughout these information outputs, it was suggested that compounds d, e, i′, and k′ might be novel and more efficacious drug candidates instead of carmofur. We believe that our characterization of mechanistic details and structural modification on M(pro)/carmofur complex will significantly intensify researchers' understanding of this system, and consequently help them to take advantage of results into practice and design various valuable derivatives for inhibition of SARS-CoV-2 main protease. Published by Elsevier B.V. 2022-01 2021-12-09 /pmc/articles/PMC8656244/ /pubmed/34904062 http://dx.doi.org/10.1016/j.rechem.2021.100259 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Hemati, Niloofar Hadidi, Saba Shiri, Farshad Farzaei, Mohammad Hosein Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation |
title | Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation |
title_full | Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation |
title_fullStr | Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation |
title_full_unstemmed | Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation |
title_short | Structural modification of antineoplastic drug carmofur designed to the inhibition of SARS-CoV-2 main protease: A theoretical investigation |
title_sort | structural modification of antineoplastic drug carmofur designed to the inhibition of sars-cov-2 main protease: a theoretical investigation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656244/ https://www.ncbi.nlm.nih.gov/pubmed/34904062 http://dx.doi.org/10.1016/j.rechem.2021.100259 |
work_keys_str_mv | AT hematiniloofar structuralmodificationofantineoplasticdrugcarmofurdesignedtotheinhibitionofsarscov2mainproteaseatheoreticalinvestigation AT hadidisaba structuralmodificationofantineoplasticdrugcarmofurdesignedtotheinhibitionofsarscov2mainproteaseatheoreticalinvestigation AT shirifarshad structuralmodificationofantineoplasticdrugcarmofurdesignedtotheinhibitionofsarscov2mainproteaseatheoreticalinvestigation AT farzaeimohammadhosein structuralmodificationofantineoplasticdrugcarmofurdesignedtotheinhibitionofsarscov2mainproteaseatheoreticalinvestigation |